Eingeschlossene Patienten: 23.474 (Stand 07. April 2025)
Amgevita® (Adalimumab)
249
Benepali® (Etanercept)
1273
Cimzia® (Certolizumab)
1049
Enbrel® (Etanercept)
2878
Erelzi® (Etanercept)
596
Flixabi® (Infliximab)
10
Hukyndra® (Adalimumab)
15
Hulio® (Adalimumab)
290
Humira® (Adalimumab)
2912
Hyrimoz® (Adalimumab)
264
Idacio® (Adalimumab)
69
Imraldi® (Adalimumab)
245
Inflectra™ (Infliximab)
16
Jyseleca® (Filgotinib)
170
Kevzara® (Sarilumab)
231
Kineret® (Anakinra)
89
MabThera® (Rituximab)
1459
Nepexto® (Etanercept)
101
Olumiant® (Baricitinib)
554
Orencia® (Abatacept)
996
Remicade® (Infliximab)
762
Remsima® (Infliximab)
27
Rinvoq® (Upadacitinib)
329
Rixathon® (Rituximab)
20
RoActemra® (Tocilizumab)
1379
Ruxience® (Rituximab)
1
Simponi® (Golimumab)
479
Truxima® (Rituximab)
5
Tyenne® (Tocilizumab)
57
Xeljanz® (Tofacitinib)
403
Yuflyma® (Adalimumab)
56
Zessly® (Infliximab)
2
Kontrollen
6488
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok